The (II)logic of iron reduction therapy for steatohepatitis

Hepatology

Volumn 62, Issue 3, 2015, Pages 668-670

  Adams, Paul C ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; IRON; IRON REGULATORY PROTEIN 1;

DISEASE ASSOCIATION; EDITORIAL; FERRITIN BLOOD LEVEL; HUMAN; IRON ABSORPTION; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; NONALCOHOLIC FATTY LIVER; PHLEBOTOMY; PRIORITY JOURNAL; FEMALE; GENETICS; MALE; METABOLISM; UPREGULATION;

FEMALE; HUMANS; IRON; IRON REGULATORY PROTEIN 1; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; UP-REGULATION;

EID: 84939652992     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27866     Document Type: Editorial

References (10)

1. Cherfane CE, Hollenbeck RD, Go J, Brown KE. Hereditary hemochromatosis: missed diagnosis or misdiagnosis? Am J Med 2013;126:1010-1015.
2. Wong K, Adams PC. The diversity of liver diseases associated with an elevated serum ferritin. Can J Gastro 2007;20:467-470.
3. Adams LA, Crawford DH, Stuart K, House MJ, St Pierre TG, Webb M, et al. The impact of phlebotomy in nonalcoholic fatty liver disease: a prospective, randomized, controlled trial. Hepatology 2015;61:1555-1564.
4. Hoki T, Miyanishi K, Tanaka S, Takada K, Kawano Y, Sakurada A, et al. Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis. Hepatology 2015;62:751-761.
5. Beaton M, Chakrabarti S, Levstik M, Speechley M, Marotta P, Adams P. Phase II clinical trial of phlebotomy therapy for non-alcoholic liver disease. Aliment Pharmacol Ther 2013;37:720-729.
6. Beaton MD, Chakrabarti S, Adams PC. Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease. Ann Hepatol 2014;13:353-356.
7. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014;46:678-684.
8. Adams PC, Barton JC, Guo H, Alter D, Speechley M. Serum ferritin is a biomarker for liver mortality in the Hemochromatosis and Iron Overload Screening Study. Ann Hepatol 2015;14:348-353.
9. Ellervik C, Marott JL, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG. Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis. Clin Chem 2014;60:1419-1428.
10. McKinnon EJ, Rossi E, Beilby JP, Trinder D, Olynyk JK. Factors that affect serum levels of ferritin in Australian adults and implications for follow-up. Clin Gastroenterol Hepatol 2014;12:101-108.